Language Select


Recent News
Feb 13, 2017

Varian Medical Systems (NYSE: VAR), today announced for the fourth year in a row, its Eclipse™ treatment planning software has been named Category Leader for Oncology Treatment Planning in the...

Feb 9, 2017

Varian Medical Systems (NYSE: VAR) today announced it won a competitive bid to provide advanced radiotherapy technology and its Eclipse™ treatment planning system to six major hospitals in...

Jan 31, 2017

One of London's leading cancer centers has commenced radiotherapy treatments at its new site using advanced TrueBeam™ medical linear accelerators from Varian Medical Systems (NYSE: VAR). The...

More news >

Recent Blog Posts
Feb 14, 2017Spot ON
Recent advancements in radiobiology research have revealed new opportunities for Proton Therapy. The application of radiobiology should allow us to further improve the therapeutic index for patients with cancer by maximising effectiveness of proton therapy whilst minimising side effects to normal tissues.
Read more
Jan 31, 2017Spot ON
Currently 8.2 million people die from cancer worldwide every year. To help draw international attention to this issue, the UICC (Union for International Cancer Control) is sponsoring its annual World Cancer Day on February 4.
Read more
Jan 24, 2017Spot ON
Healthcare organizations fight every day to save their patients’ lives. Protecting patient information is a different kind of fight. At Varian, we're working to develop software solutions that help make this data more secure so healthcare organizations can continue to focus on fighting cancer.
Read more
Corporate Communications Contacts
Spencer Sias
Vice President, Corporate Communications and Investor Relations
Mark Plungy
Director, Public Relations
Neil Madle
Director, Corporate Communications/Investor Relations, Europe
+44 (0)7786 526 068
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.